Advertisement

Correction to: Metreleptin in lipodystrophy: a profile of its use

  • Emma DeeksEmail author
Open Access
Correction
  • 43 Downloads

Correction to: Drugs & Therapy Perspectives (2019) 35:201–208  https://doi.org/10.1007/s40267-019-00622-y

The article Metreleptin in lipodystrophy: a profile of its use, written by Emma Deeks, was originally published Online First without open access. After publication in volume 35, issue 5, pages 201–208, Aegerion Pharmaceuticals requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Aegerion Pharmaceuticals. The article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

The original article has been corrected.

Copyright information

© Springer Nature 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  1. 1.SpringerAucklandNew Zealand

Personalised recommendations